Response to Letter to the Editor From Rosenfield et al: “Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome”
Helena Teede, Chau Thien Tay, Ricardo Azziz
Abstract
Journal Article Accepted manuscript Response to Letter to the Editor from Rosenfield, et al: Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome Get access Helena Teede, Helena Teede Monash Centre of Health Research and Implementation, Monash University, Melbourne Australia Corresponding author: Helena Teede - [email protected]. https://orcid.org/0000-0001-7609-577X Search for other works by this author on: Oxford Academic Google Scholar Chau Tay, Chau Tay Monash Centre of Health Research and Implementation, Monash University, Melbourne Australia Search for other works by this author on: Oxford Academic Google Scholar Ricardo Azziz Ricardo Azziz University of Alabama, Women and Infants Center, Birmingham, Alabama, USA Search for other works by this author on: Oxford Academic Google Scholar The Journal of Clinical Endocrinology & Metabolism, dgae370, https://doi.org/10.1210/clinem/dgae370 Published: 29 May 2024 Article history Received: 03 May 2024 Revision received: 21 May 2024 Editorial decision: 24 May 2024 Accepted: 28 May 2024 Published: 29 May 2024